Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

An elderly Chinese man lost all his hair after taking a new heart medication.

Alopecia can be linked to autoimmune issues, vitiligo, nail problems, and sometimes cancer treatments.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

An 8-year-old girl had nail and hair issues that improved without specific treatment, but fungal nail infection was hard to cure.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

The document is a detailed medical reference on skin and genetic disorders.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

The document concludes that hair loss in cats is caused by various factors, including allergies, mites, infections, and hormonal issues, with treatments varying accordingly.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Tofacitinib helped regrow hair in most patients with severe hair loss.